Purchase Order 75N98026P00963

<p>The National Cancer Institute awarded a purchase order to Steris Corporation valued at $10,918.04 on November 29, 2017, with an ultimate completion date of November 30, 2018. Work is performed at Bethesda, Maryland. The order procures medical sterilization equipment, services, or related solutions on a firm fixed price basis. No small business set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Steris Corporation valued at $1,528.65 on December 22, 2015, for firm fixed-price procurement of medical sterilization equipment or related supplies. Place of performance is Bethesda, Maryland. The order was scheduled for completion by February 28, 2017. No set-aside designation was used.</p>

<p>The National Cancer Institute awarded a purchase order to Steris Corporation valued at $5,106.20 on June 1, 2018, with a completion date of May 31, 2019. The order carries no set-aside designation. Place of performance is Bethesda, Maryland. The contract covers medical sterilization equipment and related services at fixed price with economic price adjustment terms.</p>

<p>The National Cancer Institute issued a purchase order to Steris Corporation for maintenance services for an autoclave, valued at $9,431.39, awarded December 1, 2014, with completion by November 30, 2015. Work is performed in Bethesda, Maryland. The order represents a de-obligation of funds from expiring FY2015 budget lines and is priced on a firm fixed-price basis with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Steris Corporation for a maintenance agreement valued at $12,047.26, with an award date of November 20, 2019 and ultimate completion on November 30, 2020. Performance is at Steris's Mentor, Ohio location. The order is priced firm fixed, with no small business set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Steris Corporation for $6,942.72 to provide maintenance services for an autoclave (Serial #011560320) at its facility in Bethesda, Maryland, effective January 31, 2018 through January 31, 2019. The order is firm fixed price with no set-aside designation applied.</p>

The National Cancer Institute awarded a $8,981.44 firm fixed-price purchase order to Steris Corporation for maintenance services on two STERIS Century SG-120 sterilizers located at the agency's Bethesda, Maryland facility. The contract, awarded December 1, 2009, with completion targeted for November 30, 2010, represents a maintenance agreement ensuring operational support for critical sterilization equipment used in the institute's research and clinical operations. No set-aside designation was...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,696.40 firm fixed price purchase order to Steris Corporation. The contract is for service agreement work to be performed in Bethesda, Maryland over an 11-month period from December 2023 through November 2024. As the prime contractor, Steris Corporation will provide unspecified services to support the National Cancer Institute's research programs. No subcontractors or set aside...

<p>The National Cancer Institute awarded a purchase order to Steris Corporation for $10,363.44 on January 1, 2015, covering firm fixed-price maintenance for two STERIS Century SG-120 sterilizers (serial numbers 0113603-09 and 0114103-10). No set-aside applied. Work is performed at Bethesda, Maryland. The order runs through December 31, 2015.</p>

The National Cancer Institute awarded a purchase order to Steris Corporation on December 6, 2017, with a ceiling value of $4,723.60. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation and an ultimate completion date of February 28, 2019. Steris manufactures and services medical sterilization equipment and related solutions for federal healthcare agencies. Invoice and payment questions should be directed to purchasing agent Carolyn Bryant at...